By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
MedsparkMedsparkMedspark
  • Home
  • News & Alerts
    News & AlertsShow More
    Samsung spinoff wins FDA clearance for AI ECG analysis software
    By
    msadmin
    October 11, 2026
    FDA clears software that builds 3D bone from a routine spine MRI
    By
    msadmin
    October 11, 2026
    Vitalize raises $31M to run hospitals like air traffic control
    By
    msadmin
    October 11, 2026
    Healthleap nets $38M to catch what hospital charts hide
    By
    msadmin
    October 11, 2026
    A robotics upstart banks $75M to build drugs without hands
    By
    msadmin
    October 11, 2026
  • Spotlight
    SpotlightShow More
    Robinhood Ventures Fund II brings retail capital to healthcare AI
    By
    msadmin
    August 13, 2026
    Adialante brings accessible MRI-based cancer screening
    By
    msadmin
    August 11, 2026
    CellType models biology so AI can discover drugs
    By
    msadmin
    August 11, 2026
    Healthcare AI startups in Robinhood Ventures Fund II
    By
    msadmin
    August 11, 2026
    OpenAI launches GPT-Rosalind for life sciences research
    By
    msadmin
    July 17, 2026
  • Articles
    ArticlesShow More
    Proteomics model picks breast cancer drugs from biopsies
    By
    msadmin
    September 10, 2026
    CRISP model reads frozen sections to steer cancer surgery
    By
    msadmin
    September 10, 2026
    Consumer chatbots are building a medical system outside hospitals
    By
    msadmin
    August 21, 2026
    Reasoning gaps hold back AI agents in scientific discovery
    By
    msadmin
    August 11, 2026
    Benchmark scores can’t track real clinical LLM use, Stanford says
    By
    msadmin
    August 11, 2026
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Font ResizerAa
MedsparkMedspark
Font ResizerAa
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
  • Shop
  • Newsletter
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Follow US
News & Alerts

AI-Powered Skin Cancer Tool DERM Rolls Out in Barking & Dagenham to Cut Wait Times and Boost Early Detection

Skin Analytics and Together First are bringing DERM, a groundbreaking autonomous AI skin cancer assessment system, to over 200,000 patients in Barking & Dagenham’s primary care network.

Yu Chi Huang
By
Yu Chi Huang
Yu Chi Huang
ByYu Chi Huang
Yu Chi is a senior regulatory affairs specialist and medical researcher focusing on medical devices.
Published: June 24, 2025
Share
3 Min Read
SHARE

As first reported by MedTech Insights, a new partnership between healthtech firm Skin Analytics and GP federation Together First is bringing the AI-powered skin cancer detection tool DERM to primary care in Barking & Dagenham. This marks the first time the technology, already used in NHS secondary care settings, will be deployed in North East London’s frontline GP services—providing faster and more accurate skin assessments to over 200,000 residents.

Contents
DERM offers fast, accurate, and autonomous assessmentsAddressing a national challenge with scalable innovationA collaborative model for the future of care

Source: skin-analytics.com.

DERM offers fast, accurate, and autonomous assessments

DERM is a CE-marked, autonomous AI platform capable of analysing moles and skin lesions for cancer without a physician’s input, boasting 99.8% accuracy—higher than the average diagnostic rate for dermatologists. By embedding DERM into Barking Community Hospital’s diagnostic centre, patients can now bypass traditional GP appointments and lengthy specialist referrals, instead booking scans directly online for faster triage.

Addressing a national challenge with scalable innovation

The rollout comes at a time when urgent skin cancer referrals have surged by 170% in the past decade across the UK, with many patients waiting weeks or months for potentially life-saving assessments. With a critical shortage of dermatologists, tools like DERM are helping to alleviate system strain by prioritizing high-risk patients and reducing unnecessary in-person appointments by up to 95%.

A collaborative model for the future of care

According to Craig Nicolic of Together First, the borough’s high care demand and limited specialist access made this AI-driven approach both timely and essential. CEO of Skin Analytics Neil Daly reinforced the human impact: “This is about ensuring people get care when they need it—not waiting in limbo.” With over 145,000 NHS patients already assessed and 14,000 cancers detected via DERM, the technology continues to prove its clinical and operational value.

By integrating DERM into local diagnostic hubs, Barking & Dagenham is setting a new precedent for AI-powered cancer detection in primary care. As Med-Tech Insights highlighted, this partnership not only brings critical diagnostics closer to patients but also showcases how intelligent systems can transform care pathways amid growing healthcare pressures.

VIA:MedTech Insights
Share This Article
Facebook Copy Link Print
Yu Chi Huang
ByYu Chi Huang
Yu Chi is a senior regulatory affairs specialist and medical researcher focusing on medical devices.

You Might Also Like

News & Alerts

Abridge rolls context-aware clinical answers out to 300 health systems

By
msadmin
August 18, 2026
News & Alerts

AI physio firm Sword Health to buy mental health app Headspace

By
msadmin
August 26, 2026
News & Alerts

AHA review finds AI echo tool catches hidden heart failure early

By
msadmin
August 3, 2026
News & Alerts

California law keeps a clinician’s judgment above the algorithm

By
msadmin
October 2, 2026

AI news, analysis, and insights for healthcare, biotech, and pharma.

Facebook Twitter Youtube Linkedin
Quick Links
  • News & Alerts
  • Articles
  • Spotlight
  • Events
About Medspark
  • Mission
  • Services
  • Contact

© Copyright 2026 MedSpark. All rights reserved.

Privacy Policy | Legal